Targeted and Immunotherapy Agents
Targeted and Immunotherapy Agents Color Key Agents in early-stage clinical trial investigations first in man, phase 1 Agents in late-stage clinical trial investigations (phases 2 and 3) FDA-approved agents FDA-approved…